On the other hand, dopamine D2 receptors play an important role in the reward circuit and in mediating both obesity and therapeutic response to antipsychotics, which may explain the association between BMI and therapeutic benefits in SZ. The gene discussed is DRD2; the disease is obesity due to melanocortin 4 receptor deficiency.